|
AU2016203803A1
|
|
Methods for reducing cd36 expression
|
|
AU2013205112A1
|
|
Influenza viruses able to infect canids, uses thereof
|
|
AU2012238228A1
|
|
Materials and methods for respiratory disease control in canines
|
|
AU2012202035A1
|
|
Methods for reducing CD36 expression
|
|
AU2011286320A1
|
|
Nematode resistant crops
|
|
AU2007328210A1
|
|
Intermediate duration neuromuscular blocking agents and antagonists thereof
|
|
AU2006326463A1
|
|
Method for identifying progressive rod-cone degeneration in dogs
|
|
AU2006304747A1
|
|
Influenza viruses able to infect canids, uses thereof
|
|
AU2006204654A1
|
|
Elastomeric functional biodegradable copolyester amides and copolyester urethanes
|
|
AU2005213318A1
|
|
Method for detection of promoter methylation status
|
|
AU2005208821A1
|
|
Methods for reducing oxidative damage
|
|
AU2004249879A1
|
|
Modulation of coffee flavour precursor levels in green coffee grains
|
|
AU2003237091A1
|
|
Tomato plants that exhibit resistance to botrytis cinerea
|
|
AU2003237805A8
|
|
Use of aav integration efficiency element for mediating site-specific integration of a transcription unit
|
|
AU2003215189A8
|
|
Endothelial precursor cells for enhancing and restoring vascular function
|
|
AU2002318169B2
|
|
Modified antibodies to prostate-specific membrane antigen and uses thereof
|
|
AU2002248535B2
|
|
Biodegradable copolymers linked to segment with a plurality of functional groups
|
